Previous studies have demonstrated that IFNγ-induced PD-L1 expression is reliant on JAK1/JAK2 activity, and that PD-L1 promoter activity and subsequent expression is mainly influenced by STAT1/STAT3 and IRF1 in IFNγ treated melanoma cells [33, 36]. The gene discussed is STAT3; the disease is melanoma.